Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study.

Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. Abstract Text:

Mayumi Sugiura-Ogasawara,Yasuhiko Ozaki,Tamao Nakanishi,Takeshi Sato,Nobuhiro Suzumori,Kyoko Kumagai,Mayumi Sugiura-Ogasawara,Yasuhiko Ozaki,Tamao Nakanishi,Takeshi Sato,Nobuhiro Suzumori,Kyoko Kumagai,

Problem It is well known that treatment with aspirin plus heparin is effective for patients with antiphospholipid syndrome (APS) to prevent pregnancy loss. However, it is unclear if occasional antiphospholipid antibodies (aPL) are a risk factor and whether patients with aPL at one time point but not diagnosed as APS should be treated. Method of study We therefore studied whether aspirin alone is effective in patients with occasional aPL who did not meet the criteria for APS. We compared live birth rates between 52 patients with occasional aPL treated with aspirin and 672 unexplained patients with no medication. Patients in both group had a history of two or three pregnancy losses. Results In all, 44 of 52 patients (84.6%) with occasional aPL could experience live birth when treated with aspirin alone. 509 of 672 patients (75.7%) with unexplained pregnancy losses could have babies. When miscarriage cases caused by an abnormal embryonic karyotype were excluded, the success rates were 95.7% (44/46) and 81.2% (509/621), respectively. The live birth rate in patients with occasional aPL treated with aspirin was significantly higher than that in unexplained patients with no medication (P = 0.008). Conclusion We therefore conclude that aspirin is also useful in patients with occasional aPL but not APS.

Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. Publishing Authors By Initials

M Sugiura-Ogasawara,Y Ozaki,T Nakanishi,T Sato,N Suzumori,K Kumagai,M Sugiura-Ogasawara,Y Ozaki,T Nakanishi,T Sato,N Suzumori,K Kumagai,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: American journal of reproductive immunology (New Y

VOLUME: 59

Page Numbers: 235-41

Journal Abbreviation: Am. J. Reprod. Immunol.

ISSN: 1046-7408

DAY: 15

MONTH: Mar

YEAR: 2008

Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8912860

Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study.

AFFILIATION: Department of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, Aichi, Japan.

Country: Denmark

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am J Reprod Immunol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study Related Publications

• A case of cutaneous myiasis due to Dermatobia hominis in Japan.
• A fragile web of understanding.
• A protease inhibitor produced by Streptomyces lividans 66 exhibits inhibitory activities toward both subtilisin BPN' and trypsin.
• Anti-Atherogenic Action of Panax ginseng in Rats and in Patients with Hyperlipidemia.
• Calcium sensitivity of sea urchin tubulin in in vitro assembly and the effects of calcium-dependent regulator (CDR) proteins isolated from sea urchin eggs and porcine brains.
• Chemical Knockdown of Protein-tyrosine Phosphatase 1B by 1,2-Naphthoquinone through Covalent Modification Causes Persistent Transactivation of Epidermal Growth Factor Receptor.
• Cytoprotective role of Nrf2/Keap1 system in methylmercury toxicity.
• Effect of site-directed mutations on processing and activity of gamma-glutamyltranspeptidase of Escherichia coli K-12.
• Effects of ionic strength, substrate and pH on inactivation of heavy meromyosin caused by low concentrations of urea.
• Effects of naphthoquinone on airway responsiveness in the presence or absence of antigen in mice.
• Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
• Enzymatic syntheses of T antigen-containing glycolipid mimicry using the transglycosylation activity of endo-alpha-N-acetylgalactosaminidase.
• Functional construction of the anti-mucin core protein (MUC1) antibody MUSE11 variable regions in a bacterial expression system.
• Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions.
• Grafting of material-binding function into antibodies Functionalization by peptide grafting.
• Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent.
• Isochronous storage ring of the New SUBARU project.
• LPT1 Encodes a Membrane-bound O-Acyltransferase Involved in the Acylation of Lysophospholipids in the Yeast Saccharomyces cerevisiae.
• Microdose clinical trial: quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry.
• Molecular modification of a novel macroporous silica-based impregnated polymeric composite by tri-n-butyl phosphate and its application in the adsorption for some metals contained in a typical simulated HLLW.
• Overestimation of serum levels of rheumatoid factor caused by the presence of an incorrect calibrator in the Dade Behring kit.
• Panning of a phage VH library using nitrocellulose membranes: application to selection of a human VH library.
• Reverse-Remodeling Effects of Angiotensin II Type 1 Receptor Blocker in a Canine Atrial Fibrillation Model.
• Role of phospholipid in adrenaline-induced lipolysis and cyclic AMP production.
• Simplified nutritional screening tools for patients on maintenance hemodialysis.
• Subunit association of gamma-glutamyltranspeptidase of Escherichia coli K-12.
• Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of Patients with Sjögren's syndrome.
• Upstream therapy for atrial fibrillation.
• [Chemical biology of 1,2-naphthoquinone, a novel air pollutant, that affects signal transduction pathways]
• [Glucocorticoid-induced osteoporosis in collagen vascular disease]